| Name | Title | Contact Details |
|---|
The Counseling Service of Addison County (CSAC) is a local community mental health center located in Middlebury, Vermont. Since 1959, CSAC has been an integral part of the Addison County community. The Counseling Service offers a wide range of professional mental health and developmental services designed to meet the needs of those seeking help. We are able to provide a multi-disciplinary approach that draws on the expertise of our staff, which includes persons trained in developmental services, substance abuse treatment, psychiatry, psychology, mental health counseling, social work, family therapy, and child therapy. Our goal is to help people live more productive lives in their communities. The following Mission Statement and Values were adopted by the CSAC Board of Directors at their October 9th, 1997 Board meeting. The Mission Statement and Values are the result of several staff and community meetings, where input was gathered. The Counseling Service of Addison County is committed to promoting stable and safe communities by helping people live emotionally healthy and satisfying lives. We strive to provide the best mental health, substance abuse, and developmental services to improve the quality of life for all community members. We work collaboratively with community organizations to help individuals and families achieve maximum wellness.
Wallace Pharma is a Decatur, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Education Review Systems is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
National Surgical Hospitals is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. National Surgical Hospitals is based in Chicago, IL. You can find more information on National Surgical Hospitals at www.nshinc.com